35
FibroBiologics closes $1.2M raise under Regulation D exemption 6(b)
Company raise · Closed · Offering $1.2M · Sold $1.2M · HOUSTON, TX · filed 2026-10-13
45
FibroBiologics, Inc. raises $4M under Reg D
Company raise · Closed · HOUSTON, TX · Form D filed 2025-12-03
First raise on EDGAR
How this compares
- Among 1,307 fund launches filed from TX in the same window it is larger than 50%; the TX median is $4M.
- No earlier fund launch by this sponsor appears on EDGAR.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
Fibrobiologics on EDGAR
Earlier and related filings by the same issuer and sponsor.
35
FibroBiologics, Inc. raises $500K under Reg D
Company raise · Closed · Offering $500K · Sold $500K · HOUSTON, TX · filed 2026-09-16
45
FibroBiologics, Inc. raises $3M under Reg D
Company raise · Closed · Offering $3M · Sold $3M · HOUSTON, TX · filed 2026-06-29
Placement agent engaged
40
FibroBiologics, Inc. raises $1.7M under Reg D
Company raise · Closed · Offering $1.7M · Sold $1.7M · HOUSTON, TX · filed 2025-12-16
Placement agent engaged
45
FibroBiologics, Inc. raises $1.5M under Reg D
Company raise · Closed · Offering $1.5M · Sold $1.5M · HOUSTON, TX · filed 2025-12-03
Placement agent engaged
People on the filing
| Pete O'Heeron | Executive Officer, Director |
| Jason D. Davis | Executive Officer |
| Richard C. Cilento | Director |
| Stacy Coen | Director |
| Victoria Niklas | Director |
| Matthew Link | Director |
| Robert Hoffman | Director |
Signed by Ruben A. Garcia, General Counsel.
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans.